We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Aviva Plc (AV.) Ordinary Shares 32 17/19 pence

Sell:457.40p Buy:457.70p 0 Change: 4.90p (1.08%)
FTSE 100:0.83%
Market closed Prices as at close on 1 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:457.40p
Buy:457.70p
Change: 4.90p (1.08%)
Market closed Prices as at close on 1 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:457.40p
Buy:457.70p
Change: 4.90p (1.08%)
Market closed Prices as at close on 1 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

HL comment (14 August 2024)

No recommendation - No news or research item is a personal recommendation to deal. All investments can fall as well as rise in value so you could get back less than you invest.

Operating profit was up by 14% to £875mn. The growth was driven by the Wealth & Retirement (IWR) and UK & Ireland General Insurance businesses. IWR benefitted from improved margins as well as a lower levels of deaths and hence life insurance pay outs in Protection and Health. Both divisions reported positive momentum on pricing.

UK & Ireland insurance growth was helped by a strong discipline in underwriting as well as improved income generated from investment positions taken by the division.

The solvency II ratio, which measures capital levels compared to requirements, dipped to 205% from 207%.

The interim dividend has been raised by 7% to 11.9p.

Medium-term guidance for £2bn of operating profit by 2026 remains unchanged.

The shares were trading flat following the announcement.

Our view

Aviva reported a solid set of first half results. Higher prices are continuing to benefit key areas like motor and home insurance where Aviva is a market leader. It takes some time for these price hikes to feed through, but the benefits are starting to be felt.

Aviva brings insurance, wealth, and retirement under one roof. The general insurance arm centres around the UK and Canada. The latter now claims the number two spot in its market. General insurance in the UK & Ireland saw more challenging conditions for parts of last year, but we’ve seen a sustained improvement so far this year.

The Probitas acquisition gives Aviva a foothold into the Lloyd’s of London insurance market. Not to be confused with the bank, it’s a unique insurance marketplace focused on taking on specialist risk. At a cost of £242mn, we think this is a unique deal that adds an asset with attractive margins and gives access to a new market.

Aviva's bulk annuity business (BPA), where it takes on final salary commitments from pension funds, has grown rapidly. The market's hot and £5.5bn of protection was sold last year. The focus continues to be on finding the right new business rather than pushing for market share. These contracts feed significant quantities of new assets into the business, which Aviva Investors can manage - increasing scale and profitability.

We wouldn’t be too surprised to see Aviva tap its formidable capital surplus to take on even more BPA business. Retirement sales did slip a little in the first half but with a very strong start to Q3 noted in the BPA business, we’re not concerned.

Being a huge workplace pension provider is behind the logic to increase its presence in the wealth management market. There are also plans to expand the advisory offering to help achieve the goal of at least 10% growth in net flows to wealth (6% in 2023). With a longer-term eye, things are moving in a good direction. But it's a challenging and crowded market, not helped by continued market volatility.

The retirement products sit alongside Aviva’s protection business (this includes products such as life assurance and income protection policies). And this year’s acquisition of AIG Life UK saw protection sales jump 49% in the first half.

Aviva is a diversified player with fingers in basically all the pies. Bulk annuities are becoming a more important part of the story, and we see scope here for growth. The big general insurance business is also attractive given the market looks to be turning more favourable. We like the mix and see the 7.6% prospective forward yield as relatively attractive, though there are no guarantees.

An independent Non-Executive director of Hargreaves Lansdown plc is also an Independent Non-Executive Director of Aviva plc.

Environmental, social and governance (ESG) risk

The financials sector is medium-risk in terms of ESG. Product governance is the largest risk for most companies, especially those in the US and Europe with enhanced regulatory scrutiny. Data privacy and security are also an increasingly important risk for banks and diversified financial firms. Business ethics, ESG integration and labour relations are also worth monitoring.

Aviva’s overall management of material ESG issues is strong.

Aviva values ESG management and focuses on transparency around key issues. The company actively addresses physical climate risks, data privacy, security, and sustainable finance. Aviva aims to boost sustainable investments by 2025 and integrates ESG factors into its investment strategies. The absence of customer satisfaction targets in FY2022 is a potential area for improvement.

Aviva key facts

  • Forward price/earnings ratio (next 12 months): 10.2

  • Ten year average forward price/earnings ratio: 6.7

  • Prospective dividend yield (next 12 months): 7.6%

  • Ten year average prospective dividend yield: 8.5%

All ratios are sourced from Refinitiv, based on previous day’s closing values. Please remember yields are variable and not a reliable indicator of future income. Keep in mind key figures shouldn’t be looked at on their own – it’s important to understand the big picture.

This article is original Hargreaves Lansdown content, published by Hargreaves Lansdown. It was correct as at the date of publication, and our views may have changed since then. Unless otherwise stated estimates, including prospective yields, are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Yields are variable and not guaranteed. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information.


Previous Aviva Plc updates

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.